- Obesity drug semaglutide fails to slow Alzheimer’s BBC
- Obesity jab drug fails to slow Alzheimer’s BBC
- Novo Nordisk shares slide after Ozempic pill fails in Alzheimer’s trials The Guardian
- Novo Nordisk (Announcement): Alzheimer’s trial disappoints Hargreaves Lansdown
- Ozempic-maker’s shares plunge after failed Alzheimer’s trial Sky News
Add Comment